Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alpha, and interleukin-2 for patients with metastatic melanoma. - Legha,S.S.; Ring,S.; Eton,O.; Bedikian,A.; Buzaid,A.C.; Plager,C.; Papadopoulos,N. (J Clin Oncol, 1998)